Skip to main content

Ivy Rx vs Sequence

A detailed head-to-head comparison of Ivy Rx and Sequence — pricing, peptides, consultation models, and patient reviews.

At a Glance

RatingNo reviews
Starting Price$175/mo
Peptides2
ConsultationAsync Telehealth
Lab TestingNo
Shipping3-5 business days

Pros

  • Flat pricing — no cost increase at higher doses
  • Microdosing option for gradual titration
  • No membership or hidden fees
  • HSA/FSA eligible
  • Multi-month plan discounts available

Cons

  • Compounded medications only
  • No insurance accepted
  • Relatively new platform with limited track record
  • No lab work included
RatingNo reviews
Starting Price$99/mo
Peptides2
ConsultationHybrid
Lab TestingNo
Shipping3-5 business days

Pros

  • Founded by obesity medicine specialists
  • Insurance-first approach can save patients hundreds per month on brand-name GLP-1 medications
  • Video consultations with experienced clinicians, not just questionnaire-based async reviews
  • Prior authorization and insurance appeals support included in membership
  • Personalized titration managed through follow-up video visits

Cons

  • Higher total cost for cash-pay patients
  • The $99/month membership is charged on top of medication costs (unlike all-inclusive platforms)
  • No published independent outcomes data for their patient population
  • Insurance navigation success varies
  • Less established brand than Hims or Ro

Pros & Cons

Peptide Pricing Comparison

PeptideIvy RxSequence
Semaglutide
$175/monthly
$99/monthly
$149/monthly
Tirzepatide
$275/monthly
Price unavailable

Frequently Asked Questions

Is Ivy Rx or Sequence better?

Ivy Rx offers 2 peptides and async telehealth consultations. Sequence offers 2 peptides and hybrid consultations. The best choice depends on which peptides you need, your budget, and preferred consultation model.

Which is cheaper, Ivy Rx or Sequence?

Ivy Rx starts at $175/month while Sequence starts at $99/month. However, pricing varies by peptide — see the pricing table above for a full breakdown.